首页> 外国专利> LIPOSOMAL DRUG DELIVERY SYSTEM FOR AMPHOTERICIN-B DRUG

LIPOSOMAL DRUG DELIVERY SYSTEM FOR AMPHOTERICIN-B DRUG

机译:两性霉素-B药物的脂质体药物输送系统

摘要

The delivery by liposome technology gives us the advantage to deliver toxic drugs to the without causing damage to the normal cells. Also, many drugs with low aqueous solubility and/or combination of both water-soluble and lipid soluble drugs can be formulated in the liposomes, increasing the bioavailability of the drug, reducing dosage and also reducing systemic toxicity. Amphotercin B is a amphiphilic drug and it is intercalated into a liposomal membrane. Amphotericin B is a antifungal used in the treatment of confirmed infections caused by various fungal species or visceral leishmaniasis, a parasitic infection. Additionally, Amp-B is used to treat patients who are refractory to or intolerant of conventional amphotericin B therapy. It is available both in the normal and liposomal injection form.
机译:通过脂质体技术进行的转运使我们能够将有毒药物转运至脂质体而不会损害正常细胞。而且,许多具有低水溶性和/或水溶性和脂溶性药物的组合的药物可以配制成脂质体,从而增加了药物的生物利用度,减少了剂量并降低了全身毒性。两性霉素B是两亲性药物,可插入脂质体膜中。两性霉素B是一种抗真菌药,用于治疗已确认的各种真菌或内脏利什曼病(一种寄生虫感染)引起的感染。此外,Amp-B用于治疗对常规两性霉素B治疗无效或不耐受的患者。它有正常和脂质体两种形式。

著录项

  • 公开/公告号IN2008MU00414A

    专利类型

  • 公开/公告日2008-06-20

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN414/MUM/2008

  • 申请日2008-02-28

  • 分类号A61K37/22;

  • 国家 IN

  • 入库时间 2022-08-21 20:07:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号